Mr. Adar Poonawalla, CEO, Serum Institute of India. The world’s largest vaccine manufacturer.
AFP (via Getty Images)
Serene Productions, headed by businessman Aadar Poonawalla, the son of Indian vaccine billionaire Cyrus Poonawalla, has shelled out Rs 10 billion (10 billion rupees) to acquire a 50% stake in Bollywood film production company Dharma Productions. agreed to invest $18 million.
The deal also includes celebrity talk show ‘Koffee and Karan’, as well as Bollywood productions such as romantic comedy ‘Rocky Aur Rani Ki Prem Kahani’ and fantasy action film ‘Brahmastra: Part 1 – Shiva’. The film’s producer, Dharma Productions, is valued at $20 billion. Rs.
After the transaction closes, Karan Johar, son of the late Yash Johar, who founded Dharma, will hold 50% of the shares, according to a statement released on Monday.
Adar Poonawalla said in a statement, “I am delighted to have the opportunity to partner with one of our country’s most iconic production houses, along with my friend Karan Johar. We look forward to building and growing Dharma and reaching greater heights. ” he said. In the next few years. ”
Dharma Productions was earlier reported to be in talks with other companies owned by billionaires, including Sanjiv Goenka’s Saregama and Mukesh Ambani’s Reliance Industries.
Dharma Productions is one of India’s leading film production companies and has produced numerous films in India and abroad over its 40-year history. In 2018, the studio founded Dharmatic Entertainment, which produces documentaries and feature films, and began producing digital content for online streaming.
Adar Poonawalla is the CEO of Serum Institute of India, the world’s largest vaccine manufacturer. The company was founded in 1966 by her father, Cyrus, who has a net worth of $24.3 billion, according to real-time data from Forbes. The Serum Institute, headquartered in Pune (about 150 kilometers southeast of Mumbai), produces more than 1.5 billion doses of a variety of vaccines, including measles, polio and influenza, annually. At the height of the pandemic, the company invested $800 million to build a new factory to manufacture coronavirus vaccines.
